Physician

Romano Nteela Abuaba, MD

According to 2025 Medicare claims, Romano Abuaba, MD (NPI: 1295014710) practices internal medicine in the Greeley, CO market, with the plurality of this provider's patient population coming from Weld, CO. This provider's primary affiliated billing organization is DESTINY INTERNAL MEDICINE PC (NPI: 1639539174; TIN: 81-1018313) and primary practice location at 80631-4293. Abuaba is affiliated with the Aledade 149 Regional MSSP (ACO ID: A5231), participating under the MSSP model.

Abuaba's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 380 traditional Medicare patients, billed 1,200 HCPCS/CPT codes, and received $112,819 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 15,688 prescription claims across 678 beneficiaries totaling $1,460,579 in drug costs, led by Eliquis (Apixaban). DME data shows 80 claims. Open Payments data shows 16 records totaling $321. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $256,252 to $112,819. In contrast, Part D prescription costs have risen steadily, from $1,021,565 to $1,460,579. For DME billing, this smaller-volume category moved from a higher plateau to a lower plateau, from $35,725 to $11,144.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	598	3,251	$256,252
2016	542	2,661	$210,257
2017	489	2,888	$231,261
2018	442	2,317	$185,310
2019	621	1,917	$160,701
2020	407	1,655	$128,821
2021	340	1,217	$100,815
2022	317	1,137	$88,502
2023	274	959	$86,300
2024	380	1,200	$112,819

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	469	17,969	$1,021,565
2016	439	15,994	$910,972
2017	462	16,598	$1,050,241
2018	448	16,675	$1,137,206
2019	804	21,935	$1,450,198
2020	815	19,169	$1,420,500
2021	695	15,502	$1,270,202
2022	627	13,243	$1,165,467
2023	641	13,702	$1,416,318
2024	678	15,688	$1,460,579

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	29	364	$20,626
2016	21	304	$9,167
2017	12	278	$14,088
2018	N/R	360	$10,244
2019	18	545	$19,274
2020	12	350	$22,460
2021	N/R	128	$12,449
2022	N/R	96	$4,271
2023	N/R	117	$5,519
2024	N/R	80	$4,782

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	32	59	$144
99306	Initial nursing facility care with high level of medical decision making, per day, if using time, 50 minutes or more	131	141	$144
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	37	37	$136
99310	Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes	51	66	$124
99309	Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes	279	670	$83

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	749	13,562	$288,044
Trulicity	Dulaglutide	81	2,078	$78,489
Orencia	Abatacept	11	308	$62,969
Mounjaro	Tirzepatide	40	1,291	$51,870
Xarelto	Rivaroxaban	112	2,488	$48,826

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	57	$3,934
E1392	Portable oxygen concentrator, rental	Y	N/R	23	$849

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	16	$321	Sumitomo Pharma America, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Romano Nteela Abuaba, MD?

Tedicare shows public-source Medicare data for Romano Nteela Abuaba, MD (NPI 1295014710), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Romano Nteela Abuaba, MD have ACO affiliation data?

Romano Nteela Abuaba, MD is shown with ACO affiliation data for Aledade 149 Regional MSSP (MSSP, ACO ID A5231).

What billing organization is linked to Romano Nteela Abuaba, MD?

Romano Nteela Abuaba, MD is linked to DESTINY INTERNAL MEDICINE PC (billing NPI 1639539174) in the available physician profile data.

Does Romano Nteela Abuaba, MD have Open Payments data?

Romano Nteela Abuaba, MD has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.